rxstat › Classes › Immunostimulants
Immunostimulants: shortage status in Canada
2 of the 10 immunostimulants rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortagePeginterferon Alfa-2a1 of 1 reported products affected · est. return Jun 30, 2026Partial shortageBacillus Calmette-guerin1 of 1 reported products affected · est. return Dec 31, 2027No current shortageAldesleukinDiscontinuedBacillus Calmette-guerin0 of 1 reported products affectedNo current shortageFilgrastimNo current shortageGlatiramerDiscontinuedInterferon Alfa-2b0 of 5 reported products affectedDiscontinuedPeginterferon Alfa-2b Ribavirin0 of 6 reported products affectedNo current shortagePlerixaforDiscontinuedWater Interferon Alfa-2b0 of 2 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.